For most of the history of biochemistry, a protein was something you found, not something you made. You could mutate one, trim it, fuse two together — but the deep grammar of how a chain of amino acids folds into a working machine stayed mostly opaque. That changed faster than most people outside the field noticed.
From prediction to design
The shift didn't start with design at all. It started with prediction: given a sequence, what shape does it fold into. Once that problem was tractable, the inverse became conceivable — given a shape you want, what sequence would produce it.
That inversion is what recent diffusion-based design tools attempt, and increasingly deliver on in the wet lab, not just in simulation.
What's actually new
Three things changed almost simultaneously:
- Structure prediction stopped being a bottleneck.
- Generative models learned to propose novel backbones, not just tweak known ones.
- Labs started validating a meaningful fraction of computational designs experimentally — closing the loop between model and bench.
None of this means arbitrary function is designable on demand. Binding a known target with a known pocket is very different from inventing a new catalytic mechanism from scratch. The honest framing is narrower than the headlines: we've gone from almost no de novo design working to some of it working, reliably enough to be useful.
What to watch next
The interesting question isn't whether the models work — it's how the failure modes evolve as design targets get harder. That's a more useful signal than any single benchmark number.